<DOC>
	<DOCNO>NCT00407264</DOCNO>
	<brief_summary>The purpose study assess efficacy fluticasone development lung cancer smoker</brief_summary>
	<brief_title>Randomized Trial Fluticasone Bronchial Premalignancy</brief_title>
	<detailed_description>Bronchial epithelium expose cigarette smoke undergoes series histological change may ultimately lead invasive cancer . In rat expose cigarette smoke inhale corticosteroid reduce number lung tumor . The purpose study assess efficacy fluticasone premalignant lesion volunteer smoke history &gt; 10 pack-years patient cure head neck cancer lung cancer . Participants screen premalignant lesion bronchoscopy present randomise receive powder inhalation device contain either fluticasone 500 Î¼g placebo . After 6 month , biopsy take location . Efficacy treatment assess reversal metaplasia/dysplasia ; secondary end-points reversal increase p53 immunoreactivity hTERT expression .</detailed_description>
	<mesh_term>Carcinoma , Bronchogenic</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>sign informed consent age 18 metaplasia index &gt; 15 % 25 pack year smoke history history lung head &amp; neck cancer male/female nonchildbearing potential use approved contraception use inhaled/systemic corticosteroid drug precede 12 month contraindication bronchoscopy/use fluticasone major illness Baseline FEV1 &lt; 1000ml Previous participation clinical study nodule &gt; 1cm CT</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2006</verification_date>
	<keyword>bronchial squamous metaplasia</keyword>
	<keyword>bronchial squamous dysplasia</keyword>
</DOC>